Vaxcyte Appoints Annie Drapeau and Teri Loxam to Its Board of Directors

NEXT STORY
Genmab and Seagen Announce FDA Accelerated Approval for TIVDAK™ (tisotumab vedotin-tftv) in Previously Treated Recurrent or Metastatic Cervical Cancer
PREV STORY
Aprea Therapeutics Presents Data From Phase 1/2 Trial of Eprenetapopt (APR-246) in Advanced Solid Tumors at ESMO Congress 2021
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Immune Design to Present at Piper Jaffray 30th Annual Healthcare Conference

SEATTLE and SOUTH SAN FRANCISCO, Calif., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Immune Design ...

author_avatar
NASDAQ Market News

Immunomedics Announces Conference Call and Webcast for First Quarter Fiscal 2017 Results

MORRIS PLAINS, N.J., Oct. 27, 2016 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU) today announced ...

author_avatar
NASDAQ Market News

Immuron Reports Significant Alleviation of Colitis Symptoms in Preclinical Program

Results confirm LPS Antagonist action of IMM-124E offers a novel therapeutic approach to induce ...

author_avatar
NASDAQ Market News